The Relationship Between Disease Severity and Various Lower Extremity Parameters in Individuals With Knee Osteoarthritis

Sponsor
Dilara Özen Oruk (Other)
Overall Status
Recruiting
CT.gov ID
NCT05294224
Collaborator
Muğla Sıtkı Koçman University (Other)
40
1
5.5
7.3

Study Details

Study Description

Brief Summary

This study perform to investigate the relationship between quadriceps femoris (QF) strength, QF thickness, femoral cartilage thickness, knee function, balance, kinesiophobia and gait of the patients with knee osteoarthritis.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Osteoarthritis (OA) is one of the most common chronic degenerative diseases in the world, which progresses slowly, can cause pain, stiffness and dysfunction, and reduces the quality of life.

    OA is particularly common in weight-bearing joints such as the knee and the functional status of patients with OA is adversely affected various factors such as immobility due to pain, decrease in muscle strength and joint range of motion, etc.

    In relation to this, walking difficulty and decrease in walking speed, balance problems and an increase in the risk of falling are a picture that can be encountered in the later stages of the disease.

    The aim of this study is to investigate the relationship between QF strength, QF thickness, femoral cartilage thickness, knee function, balance, kinesiophobia and gait of the patients with knee OA.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    The Relationship Between Disease Severity and Various Lower Extremity Parameters in Individuals With Knee Osteoarthritis
    Actual Study Start Date :
    Apr 17, 2022
    Anticipated Primary Completion Date :
    Aug 30, 2022
    Anticipated Study Completion Date :
    Sep 30, 2022

    Outcome Measures

    Primary Outcome Measures

    1. QF muscle thickness [Day 1]

      QF muscle thickness

    2. QF muscle strength [Day 1]

      QF muscle strength

    3. Femoral cartilage thickness [Day 1]

      Femoral cartilage thickness

    4. Knee function [Day 1]

      Knee function assessment with The Knee injury and Osteoarthritis Outcome Score (KOOS). It is a 42-item questionnaire, including 5 subscales: symptoms, pain, ADLs, sports/recreation, and quality of life. The maximum score a patient can achieve is 100, indicating no knee problems. The minimum score is zero, indicating severe knee problems.

    5. Kellgreen-Lawrence Radiological Stages [Day 1]

      Kellgreen-Lawrence Radiological Stages: Grade 1 (doubtful): doubtful joint space narrowing and possible osteophytic lipping. grade 2 (minimal): definite osteophytes and possible joint space narrowing. grade 3 (moderate): moderate multiple osteophytes, definite narrowing of joint space and some sclerosis and possible deformity of bone ends.

    6. Kinesiophobia [Day 1]

      Tampa Kinesiophobia Scale: The total score of the scale range from 17- 68, where 17 means no kinesiophobia, 68 means severe kinesiophobia, and score ± 37 indicates there is kinesiophobia.

    7. Balance and gait [Day 1]

      Tinetti Score: It uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16 totalling 28. The lower the score on the Tinetti test, the higher the risk of falling.

    8. Low Extremity Functionality and Fall Risk [Day 1]

      30 sec sit to stand test

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Volunteer patients who applied to the Physical therapy and Rehabilitation department with knee pain
    Exclusion Criteria:
    • Individuals who have received intra-articular therapy for gonarthrosis in the last 6 months, who have undergone arthroscopic surgery, and who have additional pathologies in their lower extremities

    • Individuals with physical, mental and/or psychological disorders that may affect participation in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mugla Sıtkı Koçman University Muğla Turkey 48000

    Sponsors and Collaborators

    • Dilara Özen Oruk
    • Muğla Sıtkı Koçman University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dilara Özen Oruk, Research Assistant, Muğla Sıtkı Koçman University
    ClinicalTrials.gov Identifier:
    NCT05294224
    Other Study ID Numbers:
    • 210077/10
    First Posted:
    Mar 24, 2022
    Last Update Posted:
    Aug 24, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dilara Özen Oruk, Research Assistant, Muğla Sıtkı Koçman University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 24, 2022